Your shopping cart is currently empty

Istaroxime is an effective inhibitor of Na+, K+-ATPase (IC50: 0.11 μM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,420 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $3,180 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $4,300 | 6-8 weeks | 6-8 weeks |
| Description | Istaroxime is an effective inhibitor of Na+, K+-ATPase (IC50: 0.11 μM). |
| Targets&IC50 | Na+, K+-ATPase:0.11 μM |
| In vitro | Istaroxime inhibits the Na+/K+-ATPase activity from the dog kidney (IC50: 0.43 ± 0.15 μM). Istaroxime acting as a positive inotropic compound through the inhibition of the Na+, K+-ATPase[2]. Inhibition of Na+/K+-ATPase activity in preparations from guinea pig kidney yielded potencies of 8.5 μM for PST2744[3]. |
| In vivo | Istaroxime (PST2744) causes a progressive to enhance in +dP/dtmax throughout the infusion. That reaches 80% (ED80) at the cumulative dose of 1.89±0.37 mg/kg and a peak of 140±3.5% at the dose (EDmax) of 4.88±0.6 mg/kg[3]. |
| Synonyms | PST2744 |
| Molecular Weight | 360.49 |
| Formula | C21H32N2O3 |
| Cas No. | 203737-93-3 |
| Smiles | C[C@]12CC[C@H]3[C@@H](CC(=O)[C@H]4C\C(CC[C@]34C)=N\OCCN)[C@@H]1CCC2=O |
| Relative Density. | 1.34 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.